Keyword Connections

drug discovery

Journals

33

1 Organic letters

2 European journal of medicinal chemistry

3 Marine drugs

4 Pharmaceuticals (Basel, Switzerland)

5 Bioorganic chemistry

6 PeerJ

7 International journal of molecular sciences

8 The Journal of organic chemistry

9 Journal of medicinal chemistry

10 Chemistry (Weinheim an der Bergstrasse, Germany)

11 Analytical chemistry

12 ChemMedChem

13 Briefings in bioinformatics

14 Rapid communications in mass spectrometry : RCM

15 analytical biochemistry

16 ACS infectious diseases

17 Nature

18 journal of cellular biochemistry

19 Cell reports

20 structure (london, england : 1993)

21 expert opinion on drug discovery

22 clinical pharmacology and therapeutics

23 omics : a journal of integrative biology

24 the american journal of cardiology

25 Archives of oral biology

26 the american journal of occupational therapy : official publication of the american occupational therapy association

27 Aging

28 Metabolites

29 current protocols in stem cell biology

30 Circulation

31 current protocols in bioinformatics

32 the journal of pharmacology and experimental therapeutics

33 kathmandu university medical journal (kumj)

Research Groups

0

No Research Group Connected

Bibliographies

109

1 In vivo evaluation of isoprenoid triazole bisphosphonate inhibitors of geranylgeranyl diphosphate synthase: impact of olefin stereochemistry on toxicity and biodistribution.

2 Exploration of Pd-catalysed four-component tandem reaction for one-pot assembly of pyrazolo[1,5-c]quinazolines as potential EGFR inhibitors.

3 acute toxicity evaluation and molecular mechanism study of antiproliferative activity of a novel indole Schiff base -diiminato manganese complex in hormone-dependent and triple negative breast cancer cells.

4 A novel molecular representation with BiGRU neural networks for learning atom.

5 Developing tool and Measuring Integration Characteristics of Basic Science Curriculum to Improve Curriculum Integration.

6 Latest advances in aging research and drug discovery.

7 A Deep Learning Model for Cell Growth Inhibition IC50 Prediction and Its Application for Gastric Cancer Patients.

8 Plakinamine P, A Steroidal Alkaloid with Bactericidal Activity against .

9 How to Illuminate the Druggable Genome Using Pharos.

10 Metabolomics in the Context of Plant Natural Products Research: From Sample Preparation to Metabolite Analysis.

11 Challenges in Alzheimer Disease Drug Discovery and Development: The Role of Modeling, Simulation and Open Data.

12 Future challenges with DNA-encoded chemical libraries in the drug discovery domain.

13 Synthesis and Bioactivity of Phthalimide Analogs as Potential Drugs to Treat Schistosomiasis, a Neglected Disease of Poverty.

14 It Is Time to Revitalize the Antibiotic Pipeline: Systems Ecology Can Help.

15 XFEL and NMR Structures of Francisella Lipoprotein Reveal Conformational Space of Drug Target against Tularemia.

16 In vitro assessment of 3-alkoxy-5-nitroindazole-derived ethylamines and related compounds as potential antileishmanial drugs.

17 Dozens of coronavirus drugs are in development - what happens next?

18 Molecular docking and in silico studies of the physicochemical properties of potential inhibitors for the phosphotransferase system of Streptococcus mutans.

19 Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary Hypertension.

20 new small-molecule drug design strategies for fighting resistant influenza a

21 a qsar approach for virtual screening of lead-like molecules en route to antitumor and antibiotic drugs from marine and microbial natural products

22 mix-and-diffuse serial synchrotron crystallography

23 innovating chinese herbal medicine: from traditional health practice to scientific drug discovery

24 the promise and challenge of induced pluripotent stem cells for cardiovascular applications

25 nanoherbals in human healthcare: a proposed research and development roadmap i

26 from mollusks to medicine: a venomics approach for the discovery and characterization of therapeutics from terebridae peptide toxins

27 the process and strategy for developing selective histone deacetylase 3 inhibitors

28 functional rescue of f508del-cftr using small molecule correctors

29 molecular docking and structure-based drug design strategies

30 analytical and experimental pharmacology, challenges ahead

31 maximum entropy in drug discovery

32 mapping protein–protein interactions of the resistance-related bacterial zeta toxin–epsilon antitoxin complex (ε2ζ2) with high affinity peptide ligands using fluorescence polarization

33 the traditional medicine and modern medicine from natural products

34 role and regulation of glutathione metabolism in plasmodium falciparum

35 A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells.

36 Holocene carbon-cycle dynamics based on CO2 trapped in ice at Taylor Dome, Antarctica

37 A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen).

38 Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer's Disease.

39 One-Pot Transformation of Hypervalent Iodines into Diversified Phenoxazine Analogues as Promising Photocatalysts.

40 Synthesis and Structure-Activity Relationship Studies of Benzo[b][1,4]oxazin-3(4H)-one Analogues as Inhibitors of Mycobacterial Thymidylate Synthase X.

41 Computational analysis to investigate the anti-rheumatic potential of plant-based small molecule inhibitor targeting tumor necrosis factor .

42 Plasmodium falciparum PFI1625c offers an opportunity to design potent anti-malarials: Biochemical characterization and testing potentials in drug discovery.

43 Artificial Intelligence: A Novel Approach for Drug Discovery.

44 Hydrogen sulphide: novel opportunity for drug discovery.

45 Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.

46 Scale, scope, and spillovers: the determinants of research productivity in drug discovery.

47 Correction: A study towards drug discovery for the management of type 2 diabetes mellitus through inhibition of the carbohydrate-hydrolyzing enzymes α-amylase and α-glucosidase by chalcone derivatives.

48 An overview of late-stage functionalization in today's drug discovery.

49 Molecular Networking As a Drug Discovery, Drug Metabolism, and Precision Medicine Strategy

50 Circadian biology and sleep in monogenic neurological disorders and its potential application in drug discovery

51 Paper spray mass spectrometry for drug analysis: an alternative to LC-MS/MS in forensic, clinical and drug discovery laboratories for dried blood spot samples

52 RNA therapeutics: Identification of novel targets leading to drug discovery.

53 Identification of a novel turn-on albumin binding small-molecule bioprobe in live zebrafish and its potential application in drug discovery

54 Multi-channel PINN: investigating scalable and transferable neural networks for drug discovery

55 A landmark in drug discovery based on complex natural product synthesis

56 AICD: an integrated anti-inflammatory compounds database for drug discovery

57 Tissue-specific genes as an underutilized resource in drug discovery

58 Machine learning-powered antibiotics phenotypic drug discovery

59 A critical evaluation of TRPA1-mediated locomotor behavior in zebrafish as a screening tool for novel anti-nociceptive drug discovery

60 Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment

61 STING modulators: Predictive significance in drug discovery

62 Engineered skeletal muscles for disease modeling and drug discovery

63 Contemporary Anti-Ebola Drug Discovery Approaches and Platforms

64 Drug discovery for chagas disease: A viewpoint

65 Nuclear Receptors: Recent Drug Discovery for Cancer Therapies

66 Unearthing fungal chemodiversity and prospects for drug discovery

67 Natural product derived privileged scaffolds in drug discovery

68 An outlook on using serial femtosecond crystallography in drug discovery

69 Cell death assays for neurodegenerative disease drug discovery

70 Chikungunya virus drug discovery: still a long way to go?

71 How can molecular micro-CT imaging revolutionize drug discovery?

72 Emerging Glycolysis Targeting and Drug Discovery from Chinese Medicine in Cancer Therapy

73 [Artificial Intelligence-based Drug Discovery and Drug Repositioning].

74 Big Data and Artificial Intelligence Modeling for Drug Discovery.

75 Applications of Quantitative Systems Pharmacology in Model-Informed Drug Discovery: Perspective on Impact and Opportunities.

76 Globally Distributed Drug Discovery of New Antibiotics: Design and Combinatorial Synthesis of Amino Acid Derivatives in the Organic Chemistry Laboratory

77 Polyphenols targeting diabetes via the AMP-activated protein kinase pathway; future approach to drug discovery.

78 Challenges to drug discovery for celiac disease and approaches to overcome them

79 Novel targets for drug discovery in celiac disease.

80 Pharmaceutical analysis combined with in-silico therapeutic and toxicological profiling on zileuton and its impurities to assist in modern drug discovery.

81 MID3: Mission Impossible or Model-Informed Drug Discovery and Development? Point-Counterpoint Discussions on Key Challenges.

82 Meeting organometallic chemistry with drug discovery: CH activation enabled discovery of a new ring system of 12H-Indazolo[2,1-a]cinnolin-12-ones with anti-proliferation activity.

83 Secure multiparty computation for privacy-preserving drug discovery.

84 Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology.

85 Synthetic biology – reimagine drug discovery

86 Applications of machine learning in drug discovery and development.

87 De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery

88 Modeling heart failure in animal models for novel drug discovery and development

89 Learning from our failures in blood–brain permeability: what can be done for new drug discovery?

90 The successes and failures of HIV drug discovery

91 A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

92 Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

93 drug discovery: past and present

94 commentary on focus in antibiotics and drug discovery from streptomycesa commentary ontoward a new focus in antibiotic and drug discovery from streptomyces arsenalby antoraz s, santamaría ri, díaz m, sanz d and rodríguez h (2015). front. microbiol. 6:461.doi: 10.3389/fmicb.2015.00461

95 drug delivery: enabling technology for drug discovery and development.iprecio® micro infusion pump: programmable, refillable and implantable

96 can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges

97 qsar-assisted virtual screening of lead-like molecules from marine and microbial natural sources for antitumor and antibiotic drug discovery

98 advanced cell culture techniques for cancer drug discovery

99 Bioactive Conformational Ensemble Server and Database. A Public Framework to Speed Up Drug Discovery.

100 applications of 19f-nmr in fragment-based drug discovery

101 a novel medium-throughput biological assay system for htlv-1 infectivity and drug discovery